Advertisement

3 Fantastic Coronavirus Vaccine Stocks to Buy Right Now

3 Fantastic Coronavirus Vaccine Stocks to Buy Right Now

Bernstein analyst Ronny Gal predicts coronavirus vaccines will generate $40 billion in sales in 2021. Johnson & Johnson (NYSE: JNJ) should announce results from a late-stage study of its COVID-19 vaccine, JNJ-78436735, very soon. It's no exaggeration to state that this vaccine could be a game changer if it proves to be safe and highly effective.